Clinical Trial Update: An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 [Phase 3]

View source ↗

Summary

Open-label Phase 3 trial of BMN 165 in adults with phenylketonuria who were not previously treated with BMN 165 has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• BMN 165

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonuria | Phase 3 | Status: COMPLETED | Results posted: 2018-09-10